916CR 916CR melb

T 000001 000 AHZ

MR SAM SAMPLE FLAT 123

123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

19March2015
DeaSr hareholder
NOTICETOELIGIBLESHAREHOL DERSOFENTITLEMENTOFFER
Wewritetoyouastheregisteredholdeorsf haresinAdmedusLtd( Admedus or Companya) s attoday'sdate.
Asannouncedon18March2015t,heCompanyisundertakinganon-renounceablepro-rata

entitlemenot ffeor nthebasiso1fnewshare( NewShare
f)oer very7sharesheldaat nissue
priceo$f 0.07perNewShare( EntitlementOffer )toraiseupto$16,141,138(beforecosts).
TheEntitlemenOt ffewr ilbl epursuanttoanoffedr ocumen(t
OffeDr ocument ).
TheEntitlemenOt ffewr ilnl obt eunderwritten.
TheEntitlemenOt ffeirsavailabletoAdmedusshareholders( Shareholdersr)egisteredonthe recorddateof7.00pm(AWST)on26March2015whoseregisteredaddressisinAustralia orNewZealand,aswellascertainprofessionaland/orsophisticatedShareholderswhose registeredaddressisinBelgium,Denmark,Germany,Luxembourg,theNetherlands,the UnitedKingdomH, ongKongoSr ingapore( EligibleShareholders ).
PurposeotfheEntitlemenOt ffer

CompletionotfheissueotfheNewSharesofferedbytheOffeDr ocumenat ndPlacemenwt ill resulitnanincreaseinthecashonhandouf p toapproximately$28M(beforethepaymenot f associatedcosts).

Samples/000001/000001


ThefundsraisedfromtheOffear ndPlacement areproposedtobeexpendedasfollows:

Description

Approximate$

Ongoingsalesteambuildandsupport

$9M

CardioCecl®ardiovasculaer xpansionstudies

$3M

Expansionorfegenerativetissueportfolio

$3.5M

Additionarlegulat oryfilings

$1M

Tissuemanufacturingscaleup andprocessdevelopment

$2M

HPVPhaseI/IpI reparation andstudyplusmanufacturing 1

$3.5M

AdditionailmmunotherapyR&D 1

$2M

Providefurthewr orkingcapital

$2.5M

CosottfheOffer

$1.5M

TotaflundsraisedundetrheOffer

$ 28M

F1 urtheirnvestmenitntothetherapeuticvaccines
IndicativeTimetable

TheindicativetimetablefotrheEntitlemenOt ffeirsasfollows:
Event Date

AnnouncemenotOf ffear ndPlacem ent

LodgemenotAf ppendix3BandCleansingSt atement

Dispatchnoticeorfightsiss uetoshareholdersandoptionholde rs

Wednesday1, 8March2015

Wednesday1, 8March2015

Thursday1, 9March2015

LodgemenotOf ffeDr ocument Friday2, 0March2015

RightsissueExDate

SettlemenotSf haresundetrhe Placement

IssueoSf haresundetrhePlac ement

RecordDate(datefodr eterminingent itlementsoEf ligibleShareholders toparticipateintheOffer)

OffeDr ocumenat ndEntitlement andShortfalFl ormsdispatchedto

EligibleShareholders

Tuesday2, 4March2015

Tuesday2, 4March2015

Wednesday2, 5March2015

Thursday2, 6March2015

Monday3, 0March2015

RightsissueoffeOr peningDate Monday3, 0March2015

Lasdt aytonotifyASXoaf nyextensiontothe RightsissueClosingDate Wednesday8A, pri2l 015

RightsissueClosingDate*

RightsissueSharesquotedonadeferredse ttlemenbt asis CompanytonotifyASXouf ndesrubscripti ons(iaf ny) RightsissueandShortfalSl hares *i*ssued DispatchholdingstatementsfoRr ightsiss ueandShortfalSl hares**

Tuesday1, 4Apri2l 015

Wednesday1, 5Apri2l 015

Thursday1, 6Apri2l 015

Monday2, 0Apri2l 015

Tuesday2, 1Apri2l 015


ThistimetableisindicativeonlyandmaybesubjecttochangeT. heCompanyreservestherightto amendthisindicativetimetableaat nytimes,ubjecttotheCorporationsAcat ndtheListingRules.
S* ubjecttotheListingRulest,heDirectorsreservetherighttoextendtheClosingDatefotrhe Offearttheidr iscretionS. houldthisoccurt,heextensionwilhl aveaconsequentiael ffecot nthe anticipate dateoifssuefotrheNewShares.
*S* hortfalol ffeirsubjecttoEligibleShareholdersnottakingupaloltfheirrightstoNewShares undetrheOffer.
ShortfalOl ffer
IntheeventthattheOffeirsnoftullysubscribedt,hedirectorsreservetherights, ubjecttoany

restrictionsimposedbythe

CorporationsAct2001(Cth)

andListingRules,toissueshortfall

sharesattheisrolediscretion(

ShortfalOl ffer ).

TheShortfalOl ffeirsaseparateoffemr
adepursuanttotheOffeDr ocumenat ndmayremain
openaftetrheClosingDateT. heissuepriceotfheshortfalslhareswilbl e$0.07eachb, eingthe samepriceastheNewSharesbeingofferedundetrheOffer.
CapitaSl tructureotfheCompany
Thetablebelowdetailsthecapitasltructureotfhe CompanyoncompletionotfheEntitlemenOt ffer:

BalanceatthedateoOf ffeDr ocumen(ttogethewr ith

Numbeor f

Shares

Numbeor f

Options

(1)

thePlacemenSt hares 1,614,113,791 107,683,401

TobeissuedundetrheEntitlemenOt ffer (2) 230,587,684 Nil

BalanceaftetrheEntitlemenOt ffer 1,844,701,475 107,683,401(1)

(1) The107,683,401Optionsconsisot f:

(i) 4,100,000Optionswithanexercisepriceo$f 0.21andanexpirydateo5Nf ovembe2r 019; (ii) 15,000,000Optionswithanexercisepriceo$f 0.17andanexpirydateo2f 1May2019;

(iii) 2,000,000Optionswithanexercisepriceo$f 0.245andanexpirydateo1Ff ebruary2019; (iv) 3,000,000Optionswithanexercisepriceo$f 0.17andanexpirydateo1Jf uly2018;

(v) 9,000,000Optionswithanexercisepriceo$f 0.27andanexpirydateo1f 6Decembe2r 018;

(vi) 15,050,067Optionswithanexercisepriceo$f 0.095andanexpirydateo1f 8June2018; (vii) 2,000,000Optionswithanexercisepriceo$f 0.06andanexpirydateo1Mf arch2018; (viii) 2,466,667Optionswithanexercisepriceo$f 0.06andanexpirydateo1f 8May2017;

(ix) 3,666,667Optionswithanexercisepriceo$f 0.06andanexpirydateo1f 0July2016a; nd

(x) 51,400,000Optionswithanexercisepriceo$f 0.06andanexpirydateo1f 0July2016.

(2) ThenumbeorNf ewSharestobeissuedundetrheO ffear ssumesthant oOptionsareexercisedbeforethe

RecordDate.

Samples/000001/000002/i12


OffeDr ocument
DetailsotfheEntitlemenOt ffear recontainedintheOffeDr ocumenwt hichwilbl elodgedwith ASXon20March2015.TheOfferDocumentisavailableontheCompany'swebsite, www.admedus.com,andtheASXwebsite.TheOfferDocumentwillbepostedtoEligible Shareholderson30March2015alongwiththeentitlemenat ndacceptanceform.
ThedirectorsencourageyoutoreadtheOffeDr o cumenct arefullyandseekadvicefromyour professionaal dviseriyf ouhave anyqueriesT.hisnoticeistoinformyouotfheEntitlement OffeYr.ouarenortequiredtodoanythinginrespecttothisletter.
Shouldyouhaveanyqueriesinrelationtothe EntitlementOffer,pleasedonothesitateto contacttheCompanyon+61892660100.
Yoursincerely

StephenMann
CompanySecretary

distributed by